While not entirely preventable, the risk of CINV can be significantly reduced with appropriate prophylactic measures. Pre-emptive administration of antiemetics before chemotherapy and tailoring treatment based on individual risk factors, such as previous experience with CINV, can help in reducing its incidence. Ongoing research into predictive biomarkers may also offer new avenues for prevention.
